ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-OR41

The Impact of Microgravity on Kidney Function During Spaceflight

Session Information

Category: Fluid‚ Electrolyte‚ and Acid-Base Disorders

  • 1001 Fluid‚ Electrolyte‚ and Acid-Base Disorders: Basic

Authors

  • Siew, Keith, University College London, London, London, United Kingdom
  • Walsh, Stephen B., University College London, London, London, United Kingdom
Background

The impact of microgravity (MG) on deep space travellers has mainly focused on cardiovascular, musculoskeletal, neurological and occular health. However, MG exposed astronauts have an unusually high rate of kidney stone formation which poses a mission critical risk. In fact, over 30 incidents have been reported and previous missions have almost been aborted due renal stone formation

Methods

To investigate this, we studied kidneys and biofluids from mice aboard the Rodent Research-10 (RR-10) Mission that launched with SpaceX-21 to the International Space Station and spent ~30 days in MG. These were compared to ground controls (n=10 per all groups) and underwent spatial transcriptomics and miRNA analysis, quantitative proteomics/phosphoproteomics, urine/plasma electrolyte analysis and 3D imaging of immunostained optically cleared tissues for histomorphometry.

Results

Thus far, our network analysis of the data supports evidence of mitochondrial damage, extracellular matrix dysfunction and decreased lomerular filtration rate. Interestly, there are also marked dysregulation in gene products relating to lipid metabolism, SLC membrane transporter superfamily and phosphorylation status.

Conclusion

Our data suggest that there are detrimental changes in the abundance and activity of key transporters/channels that either directly or indirectly regulate calcium homeostasis, and that these may be primary changes in the kidney that drive renal stone formation on the backdrop of milleu of increased renal stone risk factors (e.g. bone resorption, dehydration, enhance crystal formation in MG).